Photo of Huma Q. Rana,  MD

Huma Q. Rana, MD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute


humaq_rana@dfci.harvard.edu

Huma Q. Rana, MD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Assistant Professor, Medicine, Harvard Medical School
  • Clinical Director, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Publications

Powered by Harvard Catalyst
  • Rana HQ, Clifford J, Hoang L, LaDuca H, Black MH, Li S, McGoldrick K, Speare V, Dolinsky JS, Gau CL, Garber JE.. Genotype-phenotype associations among panel-based TP53+ subjects. 2019; 21:2478-2484.
  • Rana HQ, Sacca R, Drogan C, Gutierrez S, Schlosnagle E, Regan MM, Speare V, LaDuca H, Dolinsky J, Garber JE, Overmoyer BA.. Prevalence of germline variants in inflammatory breast cancer. Cancer 2019.
  • Rana HQ, Cochrane SR, Hiller E, Akindele RN, Nibecker CM, Svoboda LA, Cronin AM, Garber JE, Lathan CS.. A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings. 2018; 9:233-241.
  • Rana HQ, Gelman R, LaDuca H, McFarland R, Dalton E, Thompson J, Speare V, Dolinsky JS, Chao EC, Garber JE.. Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing. J Natl Cancer Inst 2018; 110:863-870.